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Introduction: Sedation overuse is frequent and possibly associated with poor outcomes in the intensive care unit
(ICU) patients. However, the association of early oversedation with clinical outcomes has not been thoroughly
evaluated. The aim of this study was to assess the association of early sedation strategies with outcomes of critically
ill adult patients under mechanical ventilation (MV).
Methods: A secondary analysis of a multicenter prospective cohort conducted in 45 Brazilian ICUs, including adult
patients requiring ventilatory support and sedation in the first 48 hours of ICU admissions, was performed. Sedation
depth was evaluated after 48 hours of MV. Multivariate analysis was used to identify variables associated with
hospital mortality.
Results: A total of 322 patients were evaluated. Overall, ICU and hospital mortality rates were 30.4% and 38.8%,
respectively. Deep sedation was observed in 113 patients (35.1%). Longer duration of ventilatory support was
observed (7 (4 to 10) versus 5 (3 to 9) days, P = 0.041) and more tracheostomies were performed in the deep
sedation group (38.9% versus 22%, P = 0.001) despite similar PaO2/FiO2 ratios and acute respiratory distress
syndrome (ARDS) severity. In a multivariate analysis, age (Odds Ratio (OR) 1.02; 95% confidence interval (CI) 1.00 to
1.03), Charlson Comorbidity Index >2 (OR 2.06; 95% CI, 1.44 to 2.94), Simplified Acute Physiology Score 3 (SAPS 3)
score (OR 1.02; CI 95%, 1.00 to 1.04), severe ARDS (OR 1.44; CI 95%, 1.09 to 1.91) and deep sedation (OR 2.36; CI
95%, 1.31 to 4.25) were independently associated with increased hospital mortality.
Conclusions: Early deep sedation is associated with adverse outcomes and constitutes an independent predictor of
hospital mortality in mechanically ventilated patients.* Correspondence: jorgesalluh@gmail.com
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Sedation is an important component of care for patients
under mechanical ventilation (MV) in the ICU. Significant
distress is related to MV itself or to routine procedural in-
terventions [1] and minimizing pain, anxiety and distress
is a major recommendation in recent guidelines [2]. Pain
and anxiety control is usually obtained with analgesics and
sedatives that ensure comfort, improve synchrony with
the ventilator and decrease work of breathing [3]. Some
studies, however, have shown that oversedation is associ-
ated with poor outcomes, including delirium, prolonged
MV, ventilator-associated pneumonia, long ICU and hos-
pital length of stay [3-6], posttraumatic stress disorder [7]
and cognitive impairment [8,9] as well as increased costs
[10-12]. Nevertheless, the issue of early sedation has seldom
been evaluated, especially in randomized controlled studies.
Despite the current recommendations [2], there is still a
significant gap between evidence from recent trials and
implementation in clinical practice [2,6,13,14]. Moreover,
to date no large randomized controlled trials of sedation
strategies used mortality as the primary outcome. In
addition, clinical trials of sedation have until now enrolled
patients mostly after 24 to 48 hours following initiation of
MV, resulting in inadequate assessment of early sedation
practice and its association with clinically relevant out-
comes [15-17].
The aim of this study is thus to describe the association
of early sedation strategies (sedation depth and sedative
choice) with clinical outcomes of mechanically ventilated
adult ICU patients, with hospital mortality as the primary
outcome.
Materials and methods
Study design, patient selection and definitions
This study was a secondary analysis of a multicenter
prospective cohort conducted in 45 Brazilian ICUs
(from the Brazilian Research in Intensive Care Network)
from 12 states between 1 June 2011 and 31 July 2011
[18]. Additional file 1 presents the participating ICUs in
more detail. In the present study, adult patients
(≥18 years old) requiring invasive ventilatory support in
the first 48 hours of ICU admission using sedatives on
the second day of MV were included.
We excluded patients submitted exclusively to noninva-
sive MV and those presenting with primary neurological
disorders. We also excluded those with missing data re-
garding sedation depth on the second day of MV. Demo-
graphic, clinical and laboratory data were collected during
the ICU stay and included cause of respiratory failure,
chronic health status, Charlson Comorbidity Index [19],
Simplified Acute Physiology Score 3 (SAPS3) [20] and the
Sequential Organ Failure Assessment (SOFA) score [21].
Data regarding the need for vasopressors, tracheostomy
and renal replacement therapy were also reported. Sepsisdiagnosis was made based on current definitions [22]. A
patient was considered to have an infection when present-
ing with suggestive clinical, laboratory, radiographic and
microbiological findings that justified the administration
of antibiotics (excluding prophylaxis) [23]. Acute respira-
tory distress syndrome (ARDS) was defined and classified
according to the Berlin definition [24].
As the primary study was not designed to evaluate sed-
ation strategies [18], the Glasgow Coma Scale (GCS) –
originally reported for SOFA score calculation – was used
as a surrogate for sedation depth. Light sedation was de-
fined as GCS ≥9 whereas those patients with GCS <9 were
considered deeply sedated. Reliability of GCS as a surro-
gate for the Richmond Agitation–Sedation Scale (RASS)
as well as selection of GCS = 9 as the cutoff value were
based on the study by Ely and colleagues that demon-
strated an excellent correlation (r = 0.91, P <0.001) be-
tween the GCS and RASS, where GCS = 9 would be
equivalent to RASS = −2 [25].
Our primary hypothesis was that early sedation strat-
egies, namely sedation depth, could be associated with
clinical outcomes including hospital mortality, so we chose
to evaluate the sedation level on the second day of MV.
The study was approved by the institutional review board
of Hospital Sírio-Libanês at the coordinating center
(Comitê de Ética em Pesquisa; approval number HSL 2010/
51) and subsequently by local review boards. Additional
file 1 describes the local review boards by participating
hospital. Due to the observational nature of the study, the
following institutions waived the need for informed con-
sent: Comitê de Ética em Pesquisa – Hospital São Camilo;
Comitê de Ética em Pesquisa – Hospital Sírio-Libanês;
Comissão de Ética para Análise de Projetos de Pesquisa –
HCFMUSP; Comitê de Ética em Pesquisa – Hospital das
Clinicas de Niteroi; Comitê de Ética em Pesquisa – Hcor;
Comitê de Ética em Pesquisa – Hospital Israelita Albert
Einstein; Comitê de Ética em Pesquisa – HCFMRP –
USP; Comitê de ética do Hospital Sao Jose; Comitê de
Ética em Pesquisa do Vitória Apart Hospital; Comitê de
Ética em Pesquisa do Hospital Madre Teresa; Comitê de
Ética em Pesquisa do Hospital da Mulher Heloneida
Studart; Comitê de Ética em Pesquisa – Hospital Moin-
hos de Vento; Comitê de Ética em Pesquisa do Hospital
Mater Dei; Comitê de Ética em pesquisa – Hospital
Mario Lioni; Comitê de Ética e Pesquisa do Hospital
Espanhol; Comitê de Ética em Pesquisa – Instituto de
Pesquisa Clínica Evandro Chagas, Fundação Oswaldo
Cruz; Comitê de Ética em Pesquisa – UNIFESP/EPM;
Comitê de Ética em Pesquisa – Hospital Copa D’or;
Comitê de Ética em Pesquisa – Beneficiência Médica Bra-
sileira S/A Hospital São Luiz; Comitê de Ética em Pes-
quisa do Hospital do Trabalhador; Comitê de Ética em
Pesquisa da Fundação de Medicina Tropical do Tocantins;
and Comitê de Ética em Pesquisa – FMUSP.
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Continuous variables are reported as the median (25 to
75% interquartile range). Univariate and multivariate
analyses using a binary logistic regression were used to
identify factors associated with the dependent variable
(hospital mortality). Variables yielding P <0.2 by univariate
analysis, or those considered clinically relevant despite P
values, were entered into the multivariate analysis to esti-
mate the independent association of each covariate with
the dependent variable. Results are presented as the odds
ratio with 95% confidence interval. A Kaplan–Meier curve
with log-rank test was used to compare patients with light
versus deep sedation for hospital mortality (censored at
day 30). Two-tailed P <0.05 was considered statistically
significant. All statistical tests were carried out using the
commercial SPSS19.0 package for Windows (SPSS Inc.,
Chicago, IL, USA).
Results
Characteristics of the study population
From 773 patients derived from the original cohort, a total
of 322 patients fulfilled the eligibility criteria (Figure 1).
Patients excluded for missing data about sedation depth
on day 2 (n = 51) were comparable with the included
population regarding demographic data, comorbidities,
physiologic and disease severity variables and outcomes
(data not shown). The main patient characteristics are pre-
sented in Table 1. Median (25 to 75% interquartile range)
age was 59 (41 to 74) years. The median SAPS3 was 61
(50 to 72) and SOFA score was 8 (6 to 11) on the first day
in the ICU. Overall ICU and hospital mortality rates were
30.4% and 38.8% respectively. When comparing nonsurvi-
vor and survivor subgroups, we observed that nonsurvi-
vors showed higher median age (68 (52 to 77) years vs. 53
(34 to 69) years, P <0.001), higher SAPS3 and SOFA score
(68 (57 to 79) vs. 57 (48 to 67), P < 0.001 and 10 (7 to 12)
vs. 8 (5 to 10), P <0.001) and higher percentage of patients
with a Charlson Comorbidity Index >2 (37.6% vs. 16.2%,
P <0.001). Those who died during hospital admission alsoFigure 1 Study flow diagram.had a higher frequency of moderate/severe ARDS (24% vs.
9.6%, P = 0.004), need for vasopressors (85.6% vs.71.1%, P =
0.003) and renal replacement therapy (33.6% vs.13.7%,
P <0.001).
Sedative choice and sedation depth
The most frequently used sedatives were the association
of midazolam and fentanyl (39.4%) or of propofol and fen-
tanyl (14%) and the use of fentanyl (12.4%) or midazolam
(8.1%) as single drugs. Sedative drug type was also associ-
ated with sedation levels: the sole administration of fen-
tanyl and dexmedetomidine was more frequent in lightly
sedated patients (15.3% vs. 7.1% for fentanyl, P = 0.033;
8.6% vs. 0.9% for dexmedetomidine, P = 0.005).
Deep sedation was observed in 113 patients (35.1%) and
was associated with a higher overall disease severity, as
demonstrated by higher median SAPS 3 (65 (54 to 78) for
deep sedation vs. 59 (48 to 70) for light sedation, P =
0.001) (Table 2). Moreover, longer duration of ventilatory
support was observed (7 (4 to 10) vs. 5 (3 to 9) days, P =
0.041) and more tracheostomies were performed in the
deep sedation group (38.9% vs. 22%, P = 0.001) despite simi-
lar arterial partial pressure of oxygen/fraction of inspired
oxygen ratios and ARDS severity. Finally, trends to in-
creased ICU and hospital mortality (37.2% vs. 26.8%, P =
0.054 and 46% vs. 34.9%, P = 0.051 respectively) were also
associated with deep sedation (Table 3). A survival curve
comparing patients with deep and light sedation is shown
in Figure 2.
In a multivariate analysis, age, Charlson Comorbidity
Index >2, SAPS3, severe ARDS and deep sedation were in-
dependently associated with increased hospital mortality
(Table 4).
Discussion
In the present multicenter cohort study we evaluated the
association of early sedation strategies with outcomes of
adult mechanically ventilated patients in the ICU. Deep
sedation in the first 48 hours of MV is a common
Table 1 General characteristics of study patients according to survival status
Characteristic Survivors (n =197) Nonsurvivors (n =125) P valuea
Age (years) 53 (34 to 69) 68 (52 to 77) <0.001
Male gender 114 (58) 73 (58) 0.925
Admission SAPS3 (points) 57 (48 to 67) 68 (57 to 79) <0.001
SOFA score day 1 (points) 8 (5 to 10) 10 (7 to 12) <0.001
Charlson comorbidity index
0 106 (53.8) 30 (24)
1 to 2 59 (29.9) 48 (38.4) <0.001
> 2 32 (16.2) 47 (37.6)
Admission source 0.038
Ward 52 (26.4) 49 (39.2)
Emergency room 79 (40.1) 46 (36.8)
Operation room 66 (33.5) 30 (24)
Cause of respiratory failure
Pneumonia 66 (33.5) 39 (31.2) 0.668
Nonpulmonary sepsis 30 (15.2) 15 (12) 0.415
Asthma/COPD 23 (11.7) 7 (5.6) 0.068
Cardiogenic pulmonary edema 11 (5.6) 9 (7.2) 0.558
Extracranial trauma 11 (5.6) 12 (9.6) 0.173
Hypovolemic/cardiogenic shock 10 (5.1) 8 (6.4) 0.614
Aspirative syndromes 10 (5.1) 3 (2.4) 0.234
Pulmonary embolism 4 (2) 5 (4) 0.296
Others 32 (16.2) 27 (21.6) 0.226
Comorbidities
Hypertension 63 (32) 58 (46.4) 0.008
Diabetes 30 (15.2) 42 (33.6) <0.001
Heart failure 12 (6.1) 14 (11.2) 0.101
COPD 12 (6.1) 12 (9.6) 0.243
Chronic renal failure 11 (5.6) 23 (18.4) <0.001
Respiratory data
ARDS mild 29 (14.7) 21 (16.8) 0.004
ARDS moderate/severe 19 (9.6) 30 (24)
PO2/FiO2 ratio 287 (220 to 350) 252 (184 to 328) 0.019
Tracheostomy 54 (27.4) 36 (28.8) 0.817
Extubation failure 23 (11.7) 19 (15.2) 0.182
Length of ventilatory support (days) 5 (3 to 8) 6 (3 to 11) 0.260
ICU support
Renal replacement therapy 27 (13.7) 42 (33.6) <0.001
Vasopressors 140 (71.1) 107 (85.6) 0.003
Outcomes
ICU length of stay (days) 11 (7 to 19) 11 (5 to 18.5) 0.389
Hospital length of stay (days) 23 (14 to 36) 14.5 (7.3 to 27) <0.001
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Table 1 General characteristics of study patients according to survival status (Continued)
Sedation depth
Light sedation 136 (69.0) 73 (58.4) 0.051
Deep sedation 61 (31.0) 52 (41.6)
Data presented as median (25 to 75% interquartile range) or n (%). ARDS, acute respiratory distress syndrome; COPD, chronic obstructive pulmonary disease;
PO2/FiO2, arterial partial pressure of oxygen/fraction of inspired oxygen; SAPS3, Simplified Acute Physiology Score 3; SOFA, Sequential Organ Failure Assessment.
aP value of the comparison between survivors and nonsurvivors.
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was associated with increased disease severity, longer dur-
ation of ventilatory support and higher need for tracheos-
tomy. In a multivariate analysis, deep sedation was an
independent factor associated with increased hospital mor-
tality (odds ratio = 2.36).Table 2 General characteristics of study patients according to
Characteristic All patients (n = 322) Li
Age (years) 59 (40.8 to 74) 61
Male gender 187 (58) 10
Charlson comorbidity index
0 136 (42.2) 72
1 to 2 107 (33.2) 75
> 2 79 (24.5) 62
Comorbidities
Hypertension 121 (37.7) 88
Diabetes 72 (22.4) 50
Heart failure 26 (8.1) 21
COPD 24 (7.5) 21
Chronic renal failure 34 (10.6) 24
Admission source
Ward 101 (31.4) 74
Emergency room 125 (38.8) 77
Operation room 96 (29.8) 58
Admission scores (points)
Admission SAPS3 61 (50 to 72) 59
SOFA score day 1 8 (6 to 11) 8
Cause of respiratory failure
Pneumonia 105 (32.6) 69
Nonpulmonary sepsis 45 (14) 30
Asthma/COPD 30 (9.3) 19
Cardiogenic pulmonary edema 20 (6.2) 15
Extracranial trauma 23 (7.1) 13
Hypovolemic/cardiogenic shock 18 (5.6) 12
Aspirative syndromes 13 (4) 9
Pulmonary embolism 9 (2.8) 6
Others 59 (18.3) 36
Data presented as median (25 to 75% interquartile range) or n (%). COPD, chronic o
SOFA, Sequential Organ Failure Assessment. aP value of the comparison between ligThe more frequently used sedative regimens in our
study were the association of midazolam and fentanyl or
of propofol and fentanyl. When compared by sedation
depth, the administration of fentanyl or dexmedetomidine
as single drugs was more frequent in lightly sedated pa-
tients (15.3% vs. 7.1% for fentanyl, P = 0.033; 8.6% vs. 0.9%sedation depth
ght sedation (n = 209) Deep sedation (n = 113) P valuea
(44 to 74.5) 55 (33.5 to 73) 0.068
8 (52) 79 (70) 0.002
(34.4) 64 (56.7) <0.001
(35.9) 32 (28.3)
(29.7) 17 (15)
(42.1) 33 (29.2) 0.026
(25.4) 22 (17.6) 0.381
(10.7) 5 (14.7) 0.077
(10) 3 (2.7) 0.016
(12.2) 10 (8) 0.463
0.103
(35.4) 27 (23.9)
(36.8) 48 (42.5)
(27.8) 38 (33.6)
(48 to 70) 65 (54 to 78) 0.001
(5 to 11) 9 (7 to 11) 0.001
(33) 36 (31.9) 0.833
(14.4) 15 (13.3) 0.790
(9.1) 11 (9.7) 0.850
(7.2) 5 (4.4) 0.329
(6.2) 10 (8.8) 0.382
(5.7) 6 (5.3) 0.872
(4.3) 4 (3.5) 0.739
(2.9) 3 (2.7) 0.911
(17.2) 23 (20.4) 0.488
bstructive pulmonary disease; SAPS3, Simplified Acute Physiology Score 3;
ht and deep sedation.
Table 3 Clinical outcomes according to sedation depth
Clinical outcomes All patients (n = 322) Light sedation (n = 209) Deep sedation (n = 113) P valuea
Respiratory data
ARDS mild 50 (15.5) 35 (16.7) 15 (13.3) 0.521
ARDS moderate/severe 49 (15.2) 35 (16.7) 14 (12.4)
PO2/FiO2 ratio 278 (208 to 339) 268 (208 to 329) 282 (208 to 353) 0.486
Tracheostomy 90 (28.3) 46 (22) 44 (38.9) 0.001
Extubation failure 42 (13.8) 32 (15.3) 10 (8.8) 0.119
Length of ventilatory support (days) 5 (3 to 9) 5 (3 to 9) 7 (4 to 10) 0.041
Ventilator-free days 17.5 (0 to 23.3) 21 (0 to 25) 0 (0 to 21) <0.001
ICU support
Renal replacement therapy 69 (21.7) 54 (25.8) 15 (13.3) 0.008
Vasopressors 247 (77.4) 162 (77.5) 85 (75.2) 0.629
Outcomes
ICU length of stay (days) 11 (6 to 19) 11 (6 to 19) 11 (6 to 18) 0.633
Hospital length of stay (days) 20 (12 to 34) 21 (13 to 35.8) 19 (10 to 27) 0.084
ICU mortality 98 (30.4) 56 (26.8) 42 (37.2) 0.054
Hospital mortality 125 (38.8) 73 (34.9) 52 (46) 0.051
Data presented as median (25 to 75% interquartile range) or n (%). ARDS, acute respiratory distress syndrome; PO2/FiO2, arterial partial pressure of oxygen/fraction
of inspired oxygen;. aP value of the comparison between light and deep sedation.
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attributed to a rapid onset and offset of action of these
drugs and their easiness to titrate, while benzodiaze-
pines are more likely to accumulate, especially during con-
tinuous infusion and when associated with other drugs
[26,27]. Recent studies demonstrate that sedation with
benzodiazepines aiming at the same target is usually asso-
ciated with a higher rate of sedation depth beyond the
target as compared with dexmedetomidine [28].
Although important studies were published recently, a
systematic review published in 2010 showed that clinical
trials on sedation are commonly reported as low quality,Figure 2 Kaplan–Meier analysis depicting the impact of sedation
depth on hospital mortality. Blue line, patients with light sedation at
day 2; red line, patients with deep sedation at day 2. P = 0.051.mainly due to their design (for example, before and after
studies), heterogeneous protocols and the relatively
small number of patients in a single center or few cen-
ters [29]. These factors generate limited evidence to guide
sedation drug choice and administration strategies in mech-
anically ventilated patients. Moreover, most studies – in-
cluding recent randomized clinical trials – have enrolled
patients 24 to 48 hours after the initiation of MV, making
the clinical relevance of sedation depth in the early period
more difficult to understand. A recent multicenter pro-
spective cohort study by Shehabi and colleagues enrolled
251 patients, aiming to characterize the patterns of early
sedation practice in 25 Australia and New Zealand (ANZ)
ICUs and to assess its relationship with relevant clinical
outcomes. After adjusting for potential confounding, early
deep sedation was a predictor of time to extubation and
mortality [30]. These results were corroborated by a co-
hort study in 11 Malaysian hospitals including medical/
surgical patients (n = 259) who were sedated and venti-
lated ≥24 hours [31]. Likewise, in our study we could as-
sess sedation strategies in the first 48 hours of MV and its
relevant clinical outcomes in a large number of patients
(n = 322), and demonstrated that early deep sedation was
an independent predictor of hospital mortality.
Unlike the other variables that were also found to be in-
dependently associated with mortality in our study, such as
ARDS severity, comorbidities and disease severity, sedation
depth is a potentially modifiable risk factor for mortality.
Implementing sedation protocols to achieve light sedation
has been proven feasible and reproducible [32,33]. This
Table 4 Factors associated with hospital mortality in a multivariate analysis
Parameter Odds ratio 95% confidence interval P value
Age 1.02 1.00 to 1.03 0.047
Charlson comorbidity index >2 2.06 1.44 to 2.94 <0.001
SAPS3 1.02 1.00 to 1.04 0.038
Severe ARDS 1.44 1.09 to 1.91 0.011
Deep sedation 2.36 1.31 to 4.25 0.004
Area under receiver operating curve for predicted mortality (95% confidence interval) = 0.768 (0.718 to 0.813), P <0.001. Hosmer–Lemeshow χ2 = 6.5670, P = 0.5840.
ARDS, acute respiratory distress syndrome; SAPS3, Simplified Acute Physiology Score 3.
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be current practice in many ICUs worldwide [5,13] and is
present in 35% of the patients enrolled in the present study.
Accordingly, Payen and colleagues observed in their survey
a large proportion of patients in a deep state of sedation,
and in addition no major changes in sedation depth or
sedative dosages occurs during the first week of the ICU
stay [34].
Finally, our findings provide validation of the concept
that early sedation has a major impact on outcomes.
Demonstrating this in a middle-income country in South
America is an important step to provide generalizability
of previous findings because the main previously pub-
lished results on this issue are from ANZ ICUs. Several
ANZ trials are well known for frequently presenting dif-
ferent results compared with similar interventions in
other parts of the world, as demonstrated by studies in
the last decade in the critical care field [35,36] and even
in the sedation area [37]. This discrepancy is attributed
to substantial differences due to the high standards in
process of care and staffing patterns, and is consequently
translated into lower mortality in ANZ ICUs [38,39].
The present study has some limitations that must be
considered. First, the sedation level was not assessed
using a specific sedation scale. Nonetheless, although
originally created to assess the level of consciousness
after head injury, it is known that GCS (the chosen
scale) <9 denotes a comatose state even in nontraumatic
settings, such as cerebral depression by pharmacological
cause [40,41]. Moreover, the GCS shows excellent cor-
relation and discrimination with the RASS (r = 0.91, P <
0.001), as described by Ely and colleagues from 1,360
paired observations among 275 adult patients in med-
ical and coronary ICUs [25]. This strong correlation be-
tween the RASS and the GCS was also shown in other
sedation scale validation studies [42,43], which allows
its applicability as a surrogate for sedation depth in the
present study.
Another limitation is the potential influence of previous
neurological status on GCS values. Data regarding GCS
on day 1 were collected in patients who were already se-
dated and under MV. A reported low GCS could therefore
be influenced by the baseline neurological status and notonly by sedation strategies, because it may also reflect
acute neurological conditions associated with the current
illness presented by the critically ill, such as encephalop-
athy. However, this is not an exclusive limitation of the
GCS because this may also occur with the more specific
sedation assessment scales such as the RASS or
Sedation-Agitation Scale (SAS). Moreover, it is possible
that certain patients may have required larger sedative
doses on day 2 of MV for other reasons (ICU proce-
dures, for instance) and we did not collect these data.
In order to minimize the impact of other conditions in
GCS values, we excluded patients with primary or
known acute neurological disorders and included only
patients under sedation in the present study. Consider-
ing the potential confounders mentioned above, the
strong association between deep sedation and mortality
must be analyzed regarding our interpretation of GCS
values mainly as a surrogate of sedation depth.
Finally, we have not evaluated the presence of delirium.
In mechanically ventilated patients, delirium is an inde-
pendent predictor of hospital and 6-month mortality
[6,44]. These outcomes are shown even in light sedated
patients, where a dose–effect response was described [45].
Despite this clinical relevance, the incidence of delirium
could not be evaluated in our study, since it was not the
aim of the primary analysis. Finally, participant ICUs re-
ported the existence of a sedation protocol, but the actual
adherence for local recommendations was not assessed in
the present study as it was beyond its initial scope.
Conclusions
Early deep sedation is associated with worse outcomes
and constitutes an independent predictor of hospital mor-
tality in a prospective cohort of mechanically ventilated
patients. Randomized clinical trials should be designed to
address the impact of light versus deep sedation in the
early phase (<48 hours) of MV.
Key messages
 Early deep sedation is associated with longer
duration of ventilator support and higher need for
tracheostomy in mechanically ventilated patients.
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http://ccforum.com/content/18/4/R156 Early sedation depth is independently associated
with increased hospital mortality.
 Sedation depth is a potentially modifiable risk factor
for adverse outcomes; future clinical trials of light
sedation with early (<24 hours) randomization of
patients should therefore be encouraged.
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